Immunocore Holdings (IMCR) Return on Sales [ROS] (2021 - 2026)
Immunocore Holdings (IMCR) recorded Return on Sales [ROS] of -2.58% in Q2 2026, up 12.60 percentage points from -15.18% a year earlier but down 9.41 percentage points from the prior quarter.
Powered by 
Analysis
Immunocore Holdings (IMCR) Return on Sales [ROS] (2021 - 2026) Analysis & Trends
On a TTM basis, Immunocore Holdings' Return on Sales [ROS] came in at -5.24% as of Jun 30, 2026, up 7.80 percentage points year-over-year; for FY2025, it came in at -11.34%, up 11.38 percentage points from FY2024.
- Annual Return on Sales [ROS] has increased for four straight years, with a five-year change of +274.88 percentage points (FY2020 to FY2025).
- Across earlier years, Return on Sales [ROS] came in at -22.71% in FY2024 (+1.20 pp), -23.91% in FY2023 (+2.73 pp), -26.64% in FY2022 (+483.08 pp) and -509.72% in FY2021 (-223.50 pp).
- Quarterly Return on Sales [ROS] has ranged from -573.82% in Q4 2021 to 14.98% in Q3 2022 over the past five years.
- On a year-over-year basis, Return on Sales [ROS] has increased for nine consecutive quarters, with an average year-over-year change of +10.43 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 537.43 percentage points in Q3 2022, against a drop of 36.79 percentage points in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 6.82% (Q1 2026), -18.85% (Q4 2025) and -6.92% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Immunocore Holdings | 1.53 Bn | -1.95 Bn | 114.84 Mn | -2.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.58% |
| Mar 31, 2026 | 6.82% |
| Dec 31, 2025 | -18.85% |
| Sep 30, 2025 | -6.92% |
| Jun 30, 2025 | -15.18% |
| Mar 31, 2025 | -3.85% |
| Dec 31, 2024 | -23.14% |
| Sep 30, 2024 | -10.59% |
| Jun 30, 2024 | -21.24% |
| Mar 31, 2024 | -37.57% |
| Dec 31, 2023 | -24.30% |
| Sep 30, 2023 | -21.81% |
| Jun 30, 2023 | -33.03% |
| Mar 31, 2023 | -26.89% |
| Dec 31, 2022 | -46.45% |
| Sep 30, 2022 | 14.98% |
| Jun 30, 2022 | -51.43% |
| Dec 31, 2021 | -573.82% |
| Sep 30, 2021 | -522.45% |
API Access
Immunocore Holdings Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IMCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();